Current Problems in Cancer
Volume 31, Issue 1 , Pages 7-25 , January 2007

Accelerated Partial Breast Irradiation

  • Gregory M. Chronowski, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Gregory M. Chronowski, MD, Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd. Unit 97, Houston, TX 77030.
    • ,
  • Thomas A. Buchholz, MD

References 

  1. Verschraegen C, Vinh-Hung V. Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96(14):1111–1112
  2. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96(2):115–121
  3. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345(19):1378–1387
  4. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15(3):963–968
  5. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143–1150
  6. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1992;10(3):356–363
  7. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92(3):269–271
  8. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356(9236):1148–1153
  9. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas (Implications for clinical trials of breast-conserving surgery). Cancer. 1985;56(5):979–990
  10. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74(5):820–824
  11. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–1241
  12. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17(8):2326–2333
  13. Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial (Uppsala-Orebro Breast Cancer Study Group). J Natl Cancer Inst. 1990;82(4):277–282
  14. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, et al. Breast conservation is a safe method in patients with small cancer of the breast (Long-term results of three randomised trials on 1,973 patients). Eur J Cancer. 1995;31A(10):1574–1579
  15. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update (Ontario Clinical Oncology Group). J Natl Cancer Inst. 1996;88(22):1659–1664
  16. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12(7):997–1003
  17. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;11(3):193–198
  18. Imamura H, Haga S, Shimizu T, Watanabe O, Kinoshita J, Nagumo H, et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat. 2000;62(3):177–184
  19. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery (Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems). Cancer. 1995;76(1):32–45
  20. American Society of Breast Surgeons (AsoB). Consensus Statement for Accelerated Partial Breast Irradiation. Available at: http://www.breastsurgeons.org/apbi.shtml.
  21. Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2003;2(2):124–130
  22. Zwicker RD, Schmidt-Ullrich R. Dose uniformity in a planar interstitial implant system. Int J Radiat Oncol Biol Phys. 1995;31(1):149–155
  23. Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A(4):608–611
  24. Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HM, Turner P, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991;27(4):447–450
  25. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch RA, White JR, et al. A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 9517 [abstract]. J Clin Oncol. 2004;22:14s
  26. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2006;65(1):45–51
  27. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95(16):1205–1210
  28. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180(4):299–304
  29. Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56(3):671–680
  30. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57(5):1239–1246
  31. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast. Ann Surg Oncol. 2006;in press
  32. Perez CA, Taylor ME, Halverson K, Garcia D, Kuske RR, Lockett MA. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1996;34(5):995–1007
  33. Hannoun-Levi JM, Marsiglia H. Brachytherapy boost for breast cancer: what do we know? (Where do we go?). Cancer Radiother. 2004;8(4):248–254
  34. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55(2):289–293
  35. Keisch M, Vicini F, Kuske R. Two-year outcome with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57(suppl 2):s315
  36. Keisch M, Vicini F, Scroggins T, al E. Thirty month results with the MammoSite breast brachytherapy applicator: cosmesis, toxicity, local control in partial breast irradiation. Int J Radiat Oncol Biol Phys. 2003;60(suppl 1):s272
  37. Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, et al. Two year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) [abstract]. J Clin Oncol. 2006;24:18s
  38. Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11(8):739–746
  39. Formenti SC, Rosenstein B, Skinner KA, Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients: pilot feasibility study. Radiology. 2002;222(1):171–178
  40. Vicini FA, Remouchamps V, Wallace M, Sharpe M, Fayad J, Tyburski L, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57(5):1247–1253
  41. Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol. 2003;30(5):596–615
  42. Veronesi U, Gatti G, Luini A, Intra M, Ciocca M, Sanchez D, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg. 2003;138(11):1253–1256
  43. Vaidya JS, Joseph D, Hilaris BS, et al. Targeted intraoperative radiotherapy for breast cancer: an international trial. 2002;21:135;Proceedings of the 21st European Society for Therapeutic Radiology and Oncology. abstr
  44. Randal J. After 40 years, mammography remains as much emotion as science. J Natl Cancer Inst. 2000;92(20):1630–1632
  45. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel-lymph-node biopsy for breast cancer–not yet the standard of care. N Engl J Med. 1998;339(14):990–995
  46. Cionini L, Pacini P, Marzano S. Exclusive brachytherapy after conservative surgery in cancer of the breast [abstract]. Lyon Chir. 1993;89:128
  47. Krishnan L, Jewell WR, Tawfik OW, Krishnan EC. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7(2):91–96
  48. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19(7):1993–2001
  49. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80(3):121–128discussion 129.
  50. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):889–897
  51. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol). 1993;5(5):278–283

PII: S0147-0272(06)00065-1

doi: 10.1016/j.currproblcancer.2006.10.001

Current Problems in Cancer
Volume 31, Issue 1 , Pages 7-25 , January 2007

Article Tools

* Image Usage & Resolution